Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Overbaugh

Showing results (131-140 of 269) with videos related to

Pageof 27
Sort By:
Journal of Virology|March 14, 2014
Association between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfectionCatherine A Blish, Ozge C Dogan, Walter Jaoko, et al.
Journal of Virology|April 11, 2008
Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted virusesZane Kraft, Katharine Strouss, William F Sutton, et al.
AIDS and Behavior|April 16, 2021
Derivation of an HIV Risk Score for African Women Who Engage in Sex WorkAlexandra C Willcox, Barbra A Richardson, Juma Shafi, et al.
Vaccine|July 4, 2012
Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentiallyFranco Pissani, Delphine C Malherbe, Harlan Robins, et al.
Biorxiv : the Preprint Server for Biology|October 13, 2021
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein after infection and/or vaccinationMeghan E Garrett, Jared G Galloway, Caitlin Wolf, et al.
AIDS Research and Human Retroviruses|October 20, 2010
Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypesBharat S Parekh, Debra L Hanson, John Hargrove, et al.
Journal of Virology|October 23, 2015
Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization SensitivitySusan Zolla-Pazner, Sandra Sharpe Cohen, David Boyd, et al.
AIDS (London, England)|December 4, 2004
Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan womenLudo Lavreys, Varsha Chohan, Julie Overbaugh, et al.
AIDS (London, England)|August 11, 2007
Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan womenJared M Baeten, Sarah Benki, Vrasha Chohan, et al.
BMC Infectious Diseases|June 6, 2013
A prospective study of endothelial activation biomarkers, including plasma angiopoietin-1 and angiopoietin-2, in Kenyan women initiating antiretroviral therapySusan M Graham, Nimerta Rajwans, Kenneth A Tapia, et al.
Pageof 27

Showing results (131-140 of 269) with videos related to

Sort By:
Pageof 27
Journal of Virology|March 14, 2014
Association between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfectionCatherine A Blish, Ozge C Dogan, Walter Jaoko, et al.
Journal of Virology|April 11, 2008
Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted virusesZane Kraft, Katharine Strouss, William F Sutton, et al.
AIDS and Behavior|April 16, 2021
Derivation of an HIV Risk Score for African Women Who Engage in Sex WorkAlexandra C Willcox, Barbra A Richardson, Juma Shafi, et al.
Vaccine|July 4, 2012
Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentiallyFranco Pissani, Delphine C Malherbe, Harlan Robins, et al.
Biorxiv : the Preprint Server for Biology|October 13, 2021
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein after infection and/or vaccinationMeghan E Garrett, Jared G Galloway, Caitlin Wolf, et al.
AIDS Research and Human Retroviruses|October 20, 2010
Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypesBharat S Parekh, Debra L Hanson, John Hargrove, et al.
Journal of Virology|October 23, 2015
Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization SensitivitySusan Zolla-Pazner, Sandra Sharpe Cohen, David Boyd, et al.
AIDS (London, England)|December 4, 2004
Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan womenLudo Lavreys, Varsha Chohan, Julie Overbaugh, et al.
AIDS (London, England)|August 11, 2007
Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan womenJared M Baeten, Sarah Benki, Vrasha Chohan, et al.
BMC Infectious Diseases|June 6, 2013
A prospective study of endothelial activation biomarkers, including plasma angiopoietin-1 and angiopoietin-2, in Kenyan women initiating antiretroviral therapySusan M Graham, Nimerta Rajwans, Kenneth A Tapia, et al.
Pageof 27